Real-World Six-Year National Cost-Minimization Analysis of IncobotulinumtoxinA and OnabotulinumtoxinA in the VA/DoD Healthcare Systems
Rashid Kazerooni, 1 Ileana M Howard, 2, 3 Adrienne M Keener, 4, 5 Mark Bounthavong 6, 7 1Merz Pharmaceuticals, LLC, Raleigh, NC, 27615, USA; 2Rehabilitation Care Services, VA Puget Sound, Seattle, WA, USA; 3Department of Rehabilitation Medicine, University of Washington, Seattle, WA, USA; 4Departmen...
Saved in:
Main Authors: | Kazerooni R (Author), Howard IM (Author), Keener AM (Author), Bounthavong M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of neurotoxic potency between a novel chinbotulinumtoxinA with onabotulinumtoxinA, incobotulinumtoxinA and lanbotulinumtoxinA in rats
by: Feng Y, et al.
Published: (2017) -
Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study
by: Rappl T, et al.
Published: (2013) -
IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations
by: Yutskovskaya Y, et al.
Published: (2015) -
Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders
by: Jost WH, et al.
Published: (2015) -
IncobotulinumtoxinA for the Treatment of Glabella and Forehead Dynamic Lines: A Real-Life Longitudinal Case Series
by: da Cunha ALG, et al.
Published: (2023)